During the past decade, Centrum Innowacyjnych Terapii Sp. z o.o. conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centrum Innowacyjnych Terapii Sp. z o.o." #1 sponsor was "Shire" with 3 trials, followed by "Janssen Research & Development, LLC" with 2 trials sponsored, "Estetra" with 1 trials sponsored, "Galapagos NV" with 1 trials sponsored and "Gilead Sciences" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centrum Innowacyjnych Terapii Sp. z o.o." #1 collaborator was "Galapagos NV" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "ICON Clinical Research" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Centrum Innowacyjnych Terapii Sp. z o.o." are "Ulcerative Colitis" (5 trials), "Acute Respiratory Infection" (1 trials), "Crohn's Disease" (1 trials), "Healthy Infants" (1 trials) and "Menopausal Symptoms" (1 trials). Many other conditions were trialed in "Centrum Innowacyjnych Terapii Sp. z o.o." in a lesser frequency.

Most popular intervention types in "Centrum Innowacyjnych Terapii Sp. z o.o." are "Drug" (7 trials), "Other" (3 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Filgotinib" (2 trials), "Ontamalimab" (2 trials), "25 mg Ontamalimab" (1 trials) and "75 mg Ontamalimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centrum Innowacyjnych Terapii Sp. z o.o." are 8 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Centrum Innowacyjnych Terapii Sp. z o.o.". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Centrum Innowacyjnych Terapii Sp. z o.o., undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Centrum Innowacyjnych Terapii Sp. z o.o., 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".